1. Home
  2. TPST vs ATER Comparison

TPST vs ATER Comparison

Compare TPST & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tempest Therapeutics Inc.

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$1.77

Market Cap

26.2M

Sector

Health Care

ML Signal

HOLD

Logo Aterian Inc.

ATER

Aterian Inc.

HOLD

Current Price

$1.19

Market Cap

7.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPST
ATER
Founded
2011
2014
Country
United States
United States
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.2M
7.7M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
TPST
ATER
Price
$1.77
$1.19
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
121.3K
11.7M
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.77
EPS
N/A
N/A
Revenue
$295,000.00
$68,975,000.00
Revenue This Year
N/A
$16.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.52
52 Week High
$12.22
$1.87

Technical Indicators

Market Signals
Indicator
TPST
ATER
Relative Strength Index (RSI) 44.42 58.04
Support Level $1.69 $0.59
Resistance Level $2.15 $1.32
Average True Range (ATR) 0.12 0.11
MACD -0.02 -0.01
Stochastic Oscillator 11.54 45.85

Price Performance

Historical Comparison
TPST
ATER

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.

About ATER Aterian Inc.

Aterian Inc is a consumer products company that operates through online retail channels, including Amazon, Walmart, Target, as well as its own direct-to-consumer websites. The company develops and manages a portfolio of owned brands, which are either internally incubated or acquired, offering products across multiple categories such as home and kitchen appliances, kitchenware, air quality appliances, health and beauty products, and essential oils. Its primary brands include Squatty Potty, HomeLabs, Mueller Living, PurSteam, Healing Solutions, and Photo Paper Direct. The company generates revenue mainly through the online sale of its consumer products, with substantially all sales derived from the Amazon U.S. marketplace.

Share on Social Networks: